TrialLancet (London, England)2019

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.

Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial ConsortiumPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.